Links

Visit Website
Request a Rep Visit

Contact Information

Carlos Rodriguez
crodriguez@esperion.com

About Exhibitor

Esperion Therapeutics is “The Lipid Management Company.” Our products – Nexletol (bempedoic acid) and Nexlizet (bempedoic acid and ezetimibe) tablets – are oral nonstatins used with diet and maximally tolerated statins to treat adults with HeFH or ASCVD who need added LDL-C lowering. The effect on cardiovascular morbidity/mortality has not been determined. Contraindication for Nexlizet is known hypersensitivity to ezetimibe. Warnings: Both increase the risk of hyperuricemia and tendon rupture. Risk Information

Resources

Product Brochure 1

Product Brochure 2